Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 9221
Corporate User License Price USD 375
Corporate User License Price INR 27664
Site License Price USD 250
Site License Price INR 18443
Request a Quote

Report Title

AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review



Executive Summary

AnaptysBio Inc (ANAB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody product candidates for the treatment of inflammatory, autoimmune and atopic diseases. The company develops its product candidates through its proprietary antibody discovery technology platform, somatic hypermutation (SHM). Its product candidates are being developed for the treatment of moderate-to-severe adult atopic dermatitis, food allergies and asthma, generalized pustular psoriasis and palmo-plantar pustular psoriasis and for the treatment of human autoimmune diseases. The company has partnership with AnaptysBio, TESARO and Celgene, to develop its product candidates. AnaptysBio is headquartered in San Diego, California, the US.

AnaptysBio Inc Key Recent Developments

May 08,2018: AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates

Mar 05,2018: AnaptysBio Reports Fourth Quarter and Full Year 2017 Financial Results

Nov 07,2017: AnaptysBio Announces Third Quarter 2017 Financial Results and Provides Pipeline Updates

Aug 24,2017: AnaptysBio Announces Appointment of J. Anthony Ware, M.D. to Board of Directors

Aug 10,2017: AnaptysBio Announces Second Quarter 2017 Financial Results and Provides Pipeline Updates

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

AnaptysBio Inc-Key Facts 5

AnaptysBio Inc-Key Employees 6

AnaptysBio Inc-Key Employee Biographies 7

AnaptysBio Inc-Major Products and Services 8

AnaptysBio Inc-History 9

AnaptysBio Inc-Company Statement 10

AnaptysBio Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

AnaptysBio Inc-Business Description 14

AnaptysBio Inc-Corporate Strategy 15

AnaptysBio Inc-SWOT Analysis 16

SWOT Analysis-Overview 16

AnaptysBio Inc-Strengths 16

AnaptysBio Inc-Weaknesses 17

AnaptysBio Inc-Opportunities 18

AnaptysBio Inc-Threats 19

AnaptysBio Inc-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

AnaptysBio Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 08, 2018: AnaptysBio Announces First Quarter 2018 Financial Results and Provides Pipeline Updates 31

Nov 07, 2017: AnaptysBio Announces Third Quarter 2017 Financial Results and Provides Pipeline Updates 33

Aug 24, 2017: AnaptysBio Announces Appointment of J. Anthony Ware, M.D. to Board of Directors 35

Aug 10, 2017: AnaptysBio Announces Second Quarter 2017 Financial Results and Provides Pipeline Updates 36

May 11, 2017: AnaptysBio Announces First Quarter 2017 Financial Results and Provides Pipeline Update 37

Mar 08, 2017: AnaptysBio Announces 2016 Operating Results and Pipeline Progress 38

Jan 11, 2017: AnaptysBio Announces The Appointment Of Dominic Piscitelli As Chief Financial Officer 40

Section 6-Appendix 41

Methodology 41

Ratio Definitions 41

About GlobalData 45

Contact Us 45

Disclaimer 45

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

AnaptysBio Inc, Performance Chart (2013-2017) 25

AnaptysBio Inc, Ratio Charts 27

AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

List of Tables

AnaptysBio Inc, Key Facts 5

AnaptysBio Inc, Key Employees 6

AnaptysBio Inc, Key Employee Biographies 7

AnaptysBio Inc, Major Products and Services 8

AnaptysBio Inc, History 9

AnaptysBio Inc, Subsidiaries 12

AnaptysBio Inc, Key Competitors 20

AnaptysBio Inc, Ratios based on current share price 21

AnaptysBio Inc, Annual Ratios 22

AnaptysBio Inc, Annual Ratios (Cont...1) 23

AnaptysBio Inc, Annual Ratios (Cont...2) 24

AnaptysBio Inc, Interim Ratios 26

AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

AnaptysBio Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

AnaptysBio Inc, Recent Deals Summary 30

Currency Codes 41

Capital Market Ratios 41

Equity Ratios 42

Profitability Ratios 42

Cost Ratios 43

Liquidity Ratios 43

Leverage Ratios 44

Efficiency Ratios 44

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

AstraZeneca Plc

Regeneron Pharmaceuticals Inc

DBV Technologies SA

Novartis AG

AnaptysBio Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand